{'fraction_non_alphanumeric': 0.019363762102351315, 'fraction_numerical': 0.0, 'mean_word_length': 5.6422018348623855, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Hypersecretion of luteinizing hormone in the polycystic ovary syndrome and a novel hormone 'gonadotrophin surge attenuating factor'.

Tonic hypersecretion of luteinizing hormone (LH) occurs only in women with the polycystic ovary syndrome (PCOS), which is a common condition affecting both fertility and pregnancy outcome. In particular, the finding of an elevated serum LH concentration has been associated with an increased risk of infertility and miscarriage. Several hypotheses exist to explain the mechanisms that lead to perturbed LH secretion. Treatment strategies have been developed to suppress serum LH levels, although whether they have a beneficial effect on conception and miscarriage rates is still uncertain.